Millennium Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-19,674
Closed -$164K 5875
2024
Q4
$164K Sell
19,674
-60,766
-76% -$531K ﹤0.01% 5366
2024
Q3
$836K Sell
80,440
-176,893
-69% -$2.94M ﹤0.01% 4417
2024
Q2
$5.07M Sell
257,333
-54,644
-18% -$1.09M ﹤0.01% 2716
2024
Q1
$7.99M Buy
311,977
+141,296
+83% +$3.62M ﹤0.01% 2408
2023
Q4
$4.71M Buy
170,681
+154,572
+960% +$9.42M ﹤0.01% 2843
2023
Q3
$979K Buy
+16,109
New +$1.13M ﹤0.01% 4206
2023
Q2
Sell
-80,958
Closed -$5.15M 6127
2023
Q1
$5.15M Buy
80,958
+44,804
+124% +$5.12M ﹤0.01% 2582
2022
Q4
$5M Sell
36,154
-46,213
-56% -$6.51M ﹤0.01% 2808
2022
Q3
$10.4M Sell
82,367
-42,074
-34% -$4.76M 0.01% 2074
2022
Q2
$10.3M Buy
124,441
+78,304
+170% +$6.07M 0.01% 1997
2022
Q1
$4.47M Buy
46,137
+19,578
+74% +$2.58M ﹤0.01% 3060
2021
Q4
$5.31M Buy
26,559
+5,614
+27% +$1.32M ﹤0.01% 2847
2021
Q3
$5.18M Sell
20,945
-11,121
-35% -$3.18M ﹤0.01% 2820
2021
Q2
$13.3M Sell
32,066
-2,015
-6% -$798K 0.01% 1576
2021
Q1
$13.3M Buy
34,081
+27,827
+445% +$13.7M 0.01% 1494
2020
Q4
$3.5M Sell
6,254
-1,875
-23% -$1.19M ﹤0.01% 2782
2020
Q3
$5.68K Sell
8,129
-6,834
-46% -$5.33M 0.01% 1724
2020
Q2
$11.8M Sell
14,963
-21,271
-59% -$16M 0.02% 1101
2020
Q1
$21.6M Buy
36,234
+17,796
+97% +$17.3M 0.05% 419
2019
Q4
$21M Buy
18,438
+12,954
+236% +$14.1M 0.03% 812
2019
Q3
$6.52M Sell
5,484
-963
-15% -$1.47M 0.01% 1596
2019
Q2
$10.6M Sell
6,447
-4,112
-39% -$7.11M 0.02% 1196
2019
Q1
$21.5M Buy
10,559
+138
+1% +$243K 0.03% 760
2018
Q4
$13.4M Buy
10,421
+4,405
+73% +$6.76M 0.02% 949
2018
Q3
$11.4M Sell
6,016
-28,458
-83% -$58.8M 0.01% 1214
2018
Q2
$70.1M Buy
+34,474
New +$78.6M 0.09% 276
2018
Q1
Sell
-1,133
Closed -$2.61M 3646
2017
Q4
$2.61M Buy
+1,133
New +$2.3M ﹤0.01% 2115
2017
Q3
Sell
-2,790
Closed -$3.8M 3513
2017
Q2
$3.8M Buy
+2,790
New +$3.37M 0.01% 1687
2016
Q4
Sell
-50,423
Closed -$44.3M 3340
2016
Q3
$44.3M Buy
50,423
+33,582
+199% +$24.3M 0.07% 285
2016
Q2
$9.44M Buy
16,841
+3,408
+25% +$1.93M 0.02% 886
2016
Q1
$7.39M Buy
13,433
+10,826
+415% +$6.65M 0.02% 1019
2015
Q4
$2.17M Sell
2,607
-9,461
-78% -$9.45M ﹤0.01% 1871
2015
Q3
$13.4M Buy
12,068
+103
+0.9% +$188K 0.03% 774
2015
Q2
$26.1M Sell
11,965
-46,127
-79% -$94M 0.05% 500
2015
Q1
$90.9M Buy
58,092
+15,922
+38% +$21M 0.17% 110
2014
Q4
$50.1M Buy
42,170
+31,952
+313% +$21.4M 0.11% 233
2014
Q3
$4.75M Sell
10,218
-703
-6% -$324K 0.01% 1324
2014
Q2
$5.46M Sell
10,921
-11,620
-52% -$3.73M 0.02% 1163
2014
Q1
$6.64M Buy
22,541
+17,657
+362% +$5.35M 0.02% 1056
2013
Q4
$1.33M Sell
4,884
-134
-3% -$37.4K ﹤0.01% 2097
2013
Q3
$1.75M Buy
+5,018
New +$1.86M 0.01% 1770

Other funds holding BLUE

Millennium Management's BLUE Position: Q1 2025 in Review

Millennium Management sold out of bluebird bio (BLUE) in Q1 2025, closing a stake of 19,674 shares — an estimated $164K sold.

Millennium Management first reported a position in BLUE in Q3 2013 and held it in 41 quarters. The position peaked at $90.9M in Q1 2015. 85 funds tracked by Wall St. Rank hold BLUE as of Q1 2025.

  • Millennium Management reported no remaining bluebird bio position as of Q1 2025 after selling out during the quarter.
  • Millennium Management sold 19,674 bluebird bio shares in Q1 2025, an estimated $164K.
  • Millennium Management first reported a position in bluebird bio in Q3 2013 and held it in 41 quarters.
  • Millennium Management's bluebird bio position peaked at $90.9M in Q1 2015.
  • 85 funds tracked by Wall St. Rank held bluebird bio as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.